DL

Dragasac Limited

Asia, Selangor, Malaysia, Ladang West Country

Description

Dragasac Limited is a wholly-owned subsidiary of Malaysian investment holding company Genting Berhad.

Investor Profile

Dragasac Limited has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dragasac Limited frequently co-invest with?

Starr Insurance
North America, New York, United States, New York
Co-Investments: 1
Sorrento Therapeutics
North America, California, United States, San Diego
Co-Investments: 1

What are some of recent deals done by Dragasac Limited?

Celularity

Florham Park, New Jersey, United States

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

BiotechnologyHealth CareTherapeuticsWellness
Post Ipo EquityJul 19, 2021
Amount Raised: $80,000,000